Industry & news·Highlights & Swiss Biotech Report
Switzerland is one of the most reputable and innovative biotech hubs in the world. Local companies hold leading positions throughout many sectors and thus attract capital, partnerships and talents from all regions.
Why Switzerland
The basis for this success is a close-knit network between research and development, driven by renowned universities, highly-specialized SMEs and strong multinational corporations.
Swiss Biotech Report
Explore the trends, figures and stories shaping Switzerland’s biotech ecosystem — an authoritative reference for members, investors, policymakers and partners worldwide.
Association chapters
Each chapter brings together leading experts, investors, talents, partners and customers within a specialized segment of the Swiss biotech ecosystem.
Advancing precision, efficiency and reliability across laboratory and diagnostic workflows
Advancing therapeutic development through digital technologies, data and AI
Developing Swiss industrial biotechnology beyond the biopharmaceutical sector toward a low-carbon, circular economy
Go deeper
Explore the Swiss biotech industry in more detail, from key players and the regulatory framework to support for early-stage companies.
Search and filter the companies of Swiss biotech, and find or add your own.
Pharma Code, Swiss Human Research Act, Nagoya Ordinance and more.
Industry associations, national & international stakeholders, support in Switzerland and abroad.
Swiss Biotech Ventures, the places to meet investors and partners, and support for start-ups and spin-offs.
The Swiss technology transfer association (swiTT) brings together professionals facilitating technology transfer from public research and educational institutions, university hospitals and other not-for-profit research organizations to the Swiss private sector.
Industry & news